Featured Research

from universities, journals, and other organizations

Blood Discovery: New Hemoglobin Type Found

Date:
March 17, 2008
Source:
University of Bonn
Summary:
Scientists have discovered a new rare type of hemoglobin. Hemoglobin transports oxygen in the red blood corpuscles. When bound to oxygen it changes color. The new hemoglobin type appears optically to be transporting little oxygen. Measurements of the blood oxygen level therefore present a similar picture to patients suffering from an inherited cardiac defect. Instruments falsely report anoxia in affected people.

Dr. Berndt Zur and colleagues have discovered a new rare type of haemoglobin.
Credit: Copyright Johann Saba, Unniversity of Bonn

Scientists at the University of Bonn have discovered a new rare type of haemoglobin. Haemoglobin transports oxygen in the red blood corpuscles. When bound to oxygen it changes colour. The new haemoglobin type appears optically to be transporting little oxygen. Measurements of the blood oxygen level therefore present a similar picture to patients suffering from an inherited cardiac defect. After examining two patients, the scientists now understand that the new type of haemoglobin distorts the level of oxygen measured.

The scientists have named the type 'Haemoglobin Bonn'. Haemoglobin transports oxygen to the body's cells and in return picks up carbon dioxide there. In doing so it changes colour. With an optical measuring instrument, known as a pulse oximeter, you can therefore measure whether there is enough oxygen present in the blood. The cause of anoxia can be an inherited cardiac defect, for example.

This was also the tentative diagnosis in the case of a four-year-old boy who was admitted to the Paediatric Clinic of the Bonn University Clinic. However, after a thorough examination, the paediatricians Dr. Andreas Hornung and his colleagues did not find any cardiac defect. A low saturation of oxygen had also been previously found in the blood of the boy's 41-year-old father, again without apparent signs of a cardiac defect.

Dr. Berndt Zur from Professor Birgit Stoffel-Wagner's team at the Institute of Clinical Chemistry and Pharmacology examined the boy's and the father's haemoglobin. He eventually realised that they were dealing with a new type of the blood pigment. 'The pulse oximeter is put on a finger as a clip and X-rays it with infrared radiation,' he explains. 'Haemoglobin absorbs infrared light in the absence of oxygen. The lower the content of oxygen in the blood, the less light penetrates the finger and reaches the sensor of the oximeter.' But Haemoglobin Bonn absorbs a bit more infrared light than normal oxygen saturated haemoglobin, even when combined with oxygen. 'That's why, at first, we did not understand why the patients did not have any particular health problems,' Dr. Zur says.

Every human has two main heart ventricles. One pumps the blood through the arteries to the lungs, where the haemoglobin releases the carbon dioxide and takes on oxygen. The other one pumps the blood which is saturated with oxygen from the lungs to every cell in the body. Both ventricles must be separated by a wall in the heart, so that the oxygen-rich blood does not mix with the anoxaemic blood. But some people have a hole in this septum.

In such cases, the pulse oximeter shows anoxia. Doctors therefore see this as a sign of a cardiac defect. Another cause is what is known as the Apnoea Syndrome. In the patients affected, breathing can cease for more than a minute. That is why the father of the 4-year-old received oxygen treatment at nights for some time. 'If we had known about Haemoglobin Bonn before, father and son could have been spared the fear of a cardiac defect or the Sleep Apnoea Syndrome,' Dr. Zur explains.

This research is published in the journal 'Clinical Chemistry'. (http:www.clinchem.org/cgi/content/full/54/3/594).


Story Source:

The above story is based on materials provided by University of Bonn. Note: Materials may be edited for content and length.


Cite This Page:

University of Bonn. "Blood Discovery: New Hemoglobin Type Found." ScienceDaily. ScienceDaily, 17 March 2008. <www.sciencedaily.com/releases/2008/03/080317102452.htm>.
University of Bonn. (2008, March 17). Blood Discovery: New Hemoglobin Type Found. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/03/080317102452.htm
University of Bonn. "Blood Discovery: New Hemoglobin Type Found." ScienceDaily. www.sciencedaily.com/releases/2008/03/080317102452.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins